Skip to main content

Table 1 Age, gender, race, and comorbidity of patients included in the study, by device type

From: Demographic and clinical profile of patients treated with proximal femoral nails – a 10-year analysis of more than 40,000 Cases

Variables

All Patients

TFNA-only

Other nails (non-TFNA) only

N

41,104

14,069

27,035

Age (mean, (standard deviation))

77.9 (SD:12.0)

77.7 (SD:12.1)

78.0 (SD:11.9)

Age Category

 less than 60

3,436 (8.4%)

1,163 (8.3%)

2,273 (8.4%)

 60 to 69

5,299 (12.9%)

1,886 (13.4%)

3,413 (12.6%)

 70 to 79

9,169 (22.3%)

3,262 (23.2%)

5,907 (21.8%)

 80 to 84

7,101 (17.3%)

2,295 (16.3%)

4,806 (17.8%)

 85 and above

16,099 (39.2%)

5,463 (38.8%)

10,636 (39.3%)

Gender: Female

28,716 (69.9%)

9,691 (68.9%)

19,025 (70.4%)

Race

 African American

1,630 (4.0%)

519 (3.7%)

1,111 (4.1%)

 Caucasian

35,463 (86.3%)

12,561 (89.3%)

22,902 (84.7%)

 Hispanic

79 (0.2%)

-

79 (0.3%)

 NA

780 (1.9%)

278 (2.0%)

502 (1.9%)

 Other

2,751 (6.7%)

499 (3.5%)

2,252 (8.3%)

 Unavailable

401 (1.0%)

212 (1.5%)

189 (0.7%)

Elixhauser Score (mean, (standard deviation))

3.3 (SD:2.0)

3.4 (SD:2.1)

3.2 (SD:2.0)

Elixhauser Category

 0

2,141 (5.2%)

668 (4.7%)

1,473 (5.4%)

 1–2

13,673 (33.3%)

4,406 (31.3%)

9,267 (34.3%)

 3–4

15,074 (36.7%)

5,121 (36.4%)

9,953 (36.8%)

 5 + 

10,216 (24.9%)

3,874 (27.5%)

6,342 (23.5%)

Severity (1 to 4)*

 1

6,342 (15.4%)

2,265 (16.1%)

4,077 (15.1%)

 2

18,340 (44.6%)

6,168 (43.8%)

12,172 (45.0%)

 3

12,940 (31.5%)

4,398 (31.3%)

8,542 (31.6%)

 4

3,482 (8.5%)

1,238 (8.8%)

2,244 (8.3%)

Risk of Mortality (1 to 4)*

 1

10,503 (25.6%)

3,517 (25.0%)

6,986 (25.8%)

 2

16,552 (40.3%)

5,442 (38.7%)

11,110 (41.1%)

 3

10,967 (26.7%)

4,003 (28.5%)

6,964 (25.8%)

 4

3,082 (7.5%)

1,107 (7.9%)

1,975 (7.3%)

Mortality during Index

810 (2.0%)

259 (1.8%)

551 (2.0%)

Femoral Shaft Fracture

966 (2.4%)

359 (2.6%)

607 (2.2%)

Head Injury

1,545 (3.8%)

996 (7.1%)

549 (2.0%)

Intensive Care Unit Use

3,835 (9.3%)

1,322 (9.4%)

2,513 (9.3%)

  1. *Risk of severity was based on the All Patient Refined (APR) hospital assessment of minor, moderate, severe or extreme, and is defined as the “extent of physiological decompensation or organ system function loss”. The APR mortality risk is simply defined as the “likelihood of dying”